SCOPUS 정보 검색 플랫폼

Biochemical and Biophysical Research Communications

Volumn 320, Issue 3, 2004, Pages 696-702

Rapid preparation of human urine and plasma samples for analysis of F 2-isoprostanes by gas chromatography-mass spectrometry

(3) Lee, Chung Yung J a Jenner, Andrew M a Halliwell, Barry a

a NATIONAL UNIVERSITY OF SINGAPORE (Singapore)

Author keywords

8 Iso PGF2 ; F2 isoprostane; GC MS NCI; iPF 2 ; Oxidative stress; SPE

Indexed keywords

ACETIC ACID ETHYL ESTER; BROMINE DERIVATIVE; F2 ISOPROSTANE; ICOSANOID; ISOPROSTANE DERIVATIVE; PENTAFLUOROBENZYLBROMIDE; PROSTAGLANDIN F2; UNCLASSIFIED DRUG;

ACIDIFICATION; ADULT; ANALYTIC METHOD; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DERIVATIZATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN URINE LEVEL; PROTEIN PURIFICATION; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; THIN LAYER CHROMATOGRAPHY; URINALYSIS;

ADULT; BLOOD CHEMICAL ANALYSIS; F2-ISOPROSTANES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; URINALYSIS;

EID: 3142528536 PISSN: 0006291X EISSN: None Source Type: Journal
DOI: 10.1016/j.bbrc.2004.06.015 Document Type: Article

Times cited : (70)

References (27)

1
- 0025572704
- 2-like compounds are produced in vivo in humans by non-cyclooxygenase, free radical-catalyzed mechanism
- 2-like compounds are produced in vivo in humans by non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA. 87:1990;9383-9387
- (1990) Proc. Natl. Acad. Sci. USA , vol.87 , pp. 9383-9387
- Morrow, J.D.¹ Hill, K.E.² Burk, R.F.³ Nammour, T.M.⁴ Badr, K.F.⁵ Roberts II, L.J.⁶

2
- 0842302396
- Isoprostanes: Novel bioactive products of lipid peroxidation
- Basu S. Isoprostanes: novel bioactive products of lipid peroxidation. Free Radic. Res. 38:2004;105-122
- (2004) Free Radic. Res. , vol.38 , pp. 105-122
- Basu, S.¹

3
- 0026667087
- 2 receptors
- 2 receptors J. Clin. Invest. 90:1992;136-141
- (1992) J. Clin. Invest. , vol.90 , pp. 136-141
- Takahashi, K.¹ Nammour, T.M.² Kukunaga, M.³ Ebert, J.⁴ Morrow, J.D.⁵ Roberts II, L.J.⁶ Hoover, R.L.⁷ Badr, K.F.⁸

4
- 0029002677
- 2-isoprostanes) in smokers
- 2-isoprostanes) in smokers. N. Engl. J. Med. 332:1995;1198-1203
- (1995) N. Engl. J. Med. , vol.332 , pp. 1198-1203
- Morrow, J.D.¹ Frei, B.² Longmire, A.W.³ Gaziano, J.M.⁴ Lynch, S.M.⁵ Shyr, Y.⁶ Strauss, W.E.⁷ Oates, J.A.⁸ Robert II, L.J.⁹

5
- 0030610106
- 2α generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo
- 2α generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo Circulation. 95:1997;2492-2499
- (1997) Circulation , vol.95 , pp. 2492-2499
- Delanty, N.¹ Reilly, M.P.² Pratico, D.³ Lawson, J.A.⁴ McCarthy, J.F.⁵ Wood, A.E.⁶ Ohnishi, S.T.⁷ Fitzgerald, D.J.⁸ Fitzgerald, G.A.⁹

6
- 0028981697
- 2α levels are elevated in individuals with non-insulin dependent diabetes mellitus
- 2α levels are elevated in individuals with non-insulin dependent diabetes mellitus FEBS Lett. 368:1995;225-229
- (1995) FEBS Lett. , vol.368 , pp. 225-229
- Gopaul, N.K.¹ Anggard, E.E.² Mallet, A.I.³ Betteridge, D.J.⁴ Wolff, S.P.⁵ Nourooz-Zadeh, J.⁶

7
- 0031991210
- Enhanced lipid peroxidation in hepatic cirrhosis
- Patrico D., Iuliano L., Basili S., Ferro D., Camastra C., Cordova C., Fitzgerald G.A., Violi F. Enhanced lipid peroxidation in hepatic cirrhosis. J. Invest. Med. 46:1998;51-57
- (1998) J. Invest. Med. , vol.46 , pp. 51-57
- Patrico, D.¹ Iuliano, L.² Basili, S.³ Ferro, D.⁴ Camastra, C.⁵ Cordova, C.⁶ Fitzgerald, G.A.⁷ Violi, F.⁸

8
- 0032557637
- 2α
- 2α FEBS Lett. 428:1998;32-36
- (1998) FEBS Lett. , vol.428 , pp. 32-36
- Basu, S.¹

9
- 10744230298
- 2α as a risk marker in patients with coronary heart disease
- 2α as a risk marker in patients with coronary heart disease Circulation. 109:2004;843-848
- (2004) Circulation , vol.109 , pp. 843-848
- Schwedhelm, E.¹ Bartling, A.² Lenzen, H.³ Tsikas, D.⁴ Maas, R.⁵ Brummer, J.⁶ Gutzki, F.M.⁷ Berger, J.⁸ Frolich, J.⁹ Boger, R.H.¹⁰

10
- 0034682916
- Lipid peroxidation, antioxidants and cardiovascular disease: How should we move forward?
- Halliwell B. Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovasc. Res. 47:2000;410-418
- (2000) Cardiovasc. Res. , vol.47 , pp. 410-418
- Halliwell, B.¹

11
- 0028834657
- 2α excretion in man
- 2α excretion in man J. Pharmacol. Exp. Ther. 275:1995;94-100
- (1995) J. Pharmacol. Exp. Ther. , vol.275 , pp. 94-100
- Wang, Z.¹ Cuabattoni, G.² Creminon, C.³ Lawson, J.⁴ Fitzgerald, G.A.⁵ Patrono, C.⁶ MacLouf, J.⁷

12
- 0345211536
- 2α) by a stable isotope dilution mass spectrometric assay
- 2α ) by a stable isotope dilution mass spectrometric assay Anal. Biochem. 269:1999;326-331
- (1999) Anal. Biochem. , vol.269 , pp. 326-331
- Morrow, J.D.¹ Zackert, W.E.² Yang, J.P.³ Kurhts, E.H.⁴ Callewaert, D.⁵ Dworski, R.⁶ Kanai, K.⁷ Traber, D.⁸ Moore, K.⁹ Oates, J.A.¹⁰ Roberts II, L.J.¹¹

13
- 0037441349
- 2α in human urine using liquid chromatography-tandem mass spectrometry
- 2α in human urine using liquid chromatography-tandem mass spectrometry Free Radic. Biol. Med. 34:2003;409-418
- (2003) Free Radic. Biol. Med. , vol.34 , pp. 409-418
- Liang, Y.¹ Wei, P.² Duke, R.W.³ Reaven, P.D.⁴ Harman, S.M.⁵ Cutler, R.⁶ Heward, C.B.⁷

14
- 2942572700
- Measuring reactive species and oxidative damage in vivo and cell culture. How should you do it and what does it mean?
- Halliwell B., Whiteman M. Measuring reactive species and oxidative damage in vivo and cell culture. How should you do it and what does it mean? Br. J. Phamacol. 142:2004;231-255
- (2004) Br. J. Phamacol. , vol.142 , pp. 231-255
- Halliwell, B.¹ Whiteman, M.²

15
- 0032491313
- 2α-VI, in human urine
- 2α -VI, in human urine J. Biol. Chem. 273:1998;29295-29301
- (1998) J. Biol. Chem. , vol.273 , pp. 29295-29301
- Lawson, J.A.¹ Li, H.² Rokach, J.³ Adiyaman, M.⁴ Hwang, S.W.⁵ Khanapures, S.P.⁶ Fitzgerald, G.A.⁷

16
- 0029002677
- 2-isoprostanes) in smokers-smoking as a cause of oxidative damage
- 2-isoprostanes) in smokers-smoking as a cause of oxidative damage. N. Engl. J. Med. 332:1995;1198-1203
- (1995) N. Engl. J. Med. , vol.332 , pp. 1198-1203
- Morrow, J.D.¹ Frei, B.² Longmire, A.W.³ Gaziano, J.M.⁴ Lynch, S.M.⁵ Shyr, Y.⁶ Strauss, W.E.⁷ Oates, J.A.⁸ Roberts II, L.J.⁹

17
- 0033105976
- 2-isoprostanes using gas chromatography-mass spectrometry
- 2-isoprostanes using gas chromatography-mass spectrometry. Anal. Biochem. 268:1999;117-125
- (1999) Anal. Biochem. , vol.268 , pp. 117-125
- Mori, T.A.¹ Croft, K.D.² Puddey, I.B.³ Beilin, L.J.⁴

18
- 0034629579
- 2-isoprostane analysis in plasma and urine high performance liquid chromatography and gas chromatography/mass spectrometry
- 2-isoprostane analysis in plasma and urine high performance liquid chromatography and gas chromatography/mass spectrometry. Anal. Biochem. 280:2000;73-89
- (2000) Anal. Biochem. , vol.280 , pp. 73-89
- Walter, M.F.¹ Blumberg, J.B.² Dolinkowski, G.G.³ Handelman, G.J.⁴

19
- 0034063593
- 2-isoprostane levels
- 2- isoprostane levels. Free Radic. Biol. Med. 28:2000;806-814
- (2000) Free Radic. Biol. Med. , vol.28 , pp. 806-814
- Gopaul, N.K.¹ Zacharowski, K.² Halliwell, B.³ Anggard, E.E.⁴

20
- 0041779429
- 2α. Possible methodological, mechanistic and clinical implications
- 2α. Possible methodological, mechanistic and clinical implications J. Chromatogr. B. 794:2003;237-255
- (2003) J. Chromatogr. B , vol.794 , pp. 237-255
- Tsikas, D.¹ Schewedhelm, E.² Suchy, M.T.³ Niemann, J.⁴ Gutzki, F.M.⁵ Erpenbeck, V.J.⁶ Hohfeld, J.M.⁷ Surdacki, A.⁸ Frolich, J.C.⁹

21
- 0032583948
- 2α-I: An index of lipid peroxidation humans
- 2α -I: an index of lipid peroxidation humans Proc. Natl. Acad. Sci. USA. 95:1998;3449-3454
- (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 3449-3454
- Pratico, D.¹ Barry, O.P.² Lawson, J.A.³ Adiyaman, M.⁴ Hwang, S.W.⁵ Khanapure, S.P.⁶ Iuliano, L.⁷ Rokach, J.⁸ Fitzgerald, G.A.⁹

22
- 0034949766
- 2-isoprostanes
- 2-isoprostanes. Clin. Chem. 47:2001;1306-1308
- (2001) Clin. Chem. , vol.47 , pp. 1306-1308
- Zhao, Z.¹ Magus Hjelm, N.² Lam, C.W.K.³ Ho, C.S.⁴

23
- 0031443007
- 2α in humans
- 2α in humans J. Mass Spectrom. 32:1997;1362-1370
- (1997) J. Mass Spectrom. , vol.32 , pp. 1362-1370
- Schweer, R.H.¹ Watzer, B.² Seyberth, H.W.³ Nusing, R.M.⁴

24
- 0033609811
- Isoprostanes: Formation, analysis and use as indices of lipid peroxidation in vivo
- Lawson J.A., Rokach J., Fitzgerald G.A. Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J. Biol. Chem. 274:1999;24441-24444
- (1999) J. Biol. Chem. , vol.274 , pp. 24441-24444
- Lawson, J.A.¹ Rokach, J.² Fitzgerald, G.A.³

25
- 0032586084
- 2-Isoprostane excretion rate and diurnal variation in human urine
- 2-Isoprostane excretion rate and diurnal variation in human urine. Prostaglandins Leukot. Essent. Fatty Acids. 61:1999;203-205
- (1999) Prostaglandins Leukot. Essent. Fatty Acids , vol.61 , pp. 203-205
- Helmersson, J.¹ Basu, S.²

26
- 0032829394
- Urinary isoprostane excretion is not confounded by the lipid content of the diet
- Richelle M., Turini M.E., Guidoux R., Tavazzi S., Metairon S., Fay L.B. Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Lett. 459:1999;259-262
- (1999) FEBS Lett. , vol.459 , pp. 259-262
- Richelle, M.¹ Turini, M.E.² Guidoux, R.³ Tavazzi, S.⁴ Metairon, S.⁵ Fay, L.B.⁶

27
- 0033624024
- 2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet
- 2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet. Free Radic. Res. 33:2000;115-127
- (2000) Free Radic. Res. , vol.33 , pp. 115-127
- Gopaul, N.K.¹ Halliwell, B.² Anggard, E.E.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.